Linked e-resources
Details
Table of Contents
Intro; Pediatric Oncologic Pharmacy; A Complete Guide to Practice; Copyright; Acknowledgments; Abbreviations; Contents; About the Author; Chapter 1: Introduction; 1.1 The Pharmacist and Chemotherapy in Children; 1.2 Pharmacist in Pediatric Hemato/Oncological Area; 1.3 Pharmacist in Rheumatology Area: Chemotherapy for Rheumatic Children; 1.4 Chemotherapy in Children; 1.5 Chemotherapy in Neonates and Infants; Chapter 2: Diseases in Pediatric Hemato/Oncology Area and Treatments; 2.1 Acute Lymphoid Leukemia; 2.1.1 Induction; 2.1.2 Consolidation; 2.1.3 Maintenance; 2.1.4 BFM Protocol
2.1.5 Conclusion About Protocols for ALL Pediatric Treatment2.1.6 Drugs Commonly Used for Pediatric ALL; 2.1.7 CAR T-Cell; 2.2 Acute Myeloid Leukemia; 2.2.1 Chemotherapy; 2.2.2 Stem Cell Transplantation; 2.2.3 SCT for Pediatric Refractory AML; 2.3 Chronic Myeloid Leukemia (CML); 2.3.1 Chemotherapy; 2.3.2 SCT for CML; 2.3.3 A "Big Picture" of the Pediatric CML Treatment; 2.4 Hodgkin Lymphoma; 2.4.1 Chemotherapy; 2.5 Non-Hodgkin Lymphoma; 2.5.1 Chemotherapy; 2.6 Osteosarcoma; 2.6.1 Chemotherapy; 2.6.2 Folinic Acid Mechanism; 2.7 Central Nervous System Tumors; 2.7.1 Treatment; 2.8 Retinoblastoma
2.8.1 Treatment2.8.1.1 Chemotherapy; 2.9 Wilms Tumor; 2.9.1 Treatment; 2.10 Hepatoblastoma; 2.10.1 Treatment; 2.11 Congenital Tumors; 2.11.1 Treatment; Chapter 3: Diseases in Rheumatology and Their Treatment with Chemotherapy; 3.1 Sometimes Symptoms of Rheumatic diseases Are, Actually, First Sign of Pediatric Cancer; 3.2 Rheumatic Diseases in Children and Their Treatments; 3.2.1 Pediatric Systemic Lupus Erythematosus; 3.2.2 Pediatric Idiopathic Arthritis; 3.2.3 Pediatric Dermatomyositis; 3.2.4 Pediatric Scleroderma; 3.2.5 Pediatric Kawasaki Disease
3.2.6 Pediatric Mixed Connective Tissue Disease3.2.7 Pediatric Fibromyalgia; 3.2.8 Rheumatic Diseases in Neonates and Infants; Chapter 4: Pharmacokinetics and Pharmacodynamics of Chemotherapy in Children: The Most Used Drugs; 4.1 6-mercaptopurine; 4.2 Bevacizumab; 4.3 Bleomycin; 4.4 Brentuximab; 4.5 Busulfan; 4.6 Carboplatin; 4.7 Carmustine; 4.8 Cisplatin; 4.9 Cyclophosphamide; 4.10 Cytarabine; 4.11 Dacarbazine; 4.12 Dactinomycin; 4.13 Daunorubicin; 4.14 Docetaxel; 4.15 Doxorubicin; 4.16 Etoposide; 4.17 Fludarabine; 4.18 Gemcitabine; 4.19 Hydroxyurea; 4.20 Idarubicin; 4.21 Ifosfamide
4.22 Imatinib4.23 Irinotecan; 4.24 Lomustine; 4.25 L-asparaginase; 4.26 Methotrexate; 4.27 Mitoxantrone; 4.28 Paclitaxel; 4.29 Thioguanine; 4.30 Trans-retinoic Acid; 4.31 Vinblastine; 4.32 Vincristine; 4.33 Vinorelbine; Chapter 5: Handling Parenteral Drugs Used in Chemotherapy for Children; 5.1 Brentuximab; 5.2 Bleomycin; 5.3 Busulfan; 5.4 Carboplatin; 5.5 Carmustine; 5.6 Cisplatin; 5.7 Cyclophosphamide; 5.8 Cytarabine; 5.9 Dacarbazine; 5.10 Dactinomycin; 5.11 Daunorubicin; 5.12 Docetaxel; 5.13 Doxorubicin; 5.14 Etoposide; 5.15 Fludarabine; 5.16 Gemcitabine; 5.17 Idarubicin; 5.18 Ifosfamide
2.1.5 Conclusion About Protocols for ALL Pediatric Treatment2.1.6 Drugs Commonly Used for Pediatric ALL; 2.1.7 CAR T-Cell; 2.2 Acute Myeloid Leukemia; 2.2.1 Chemotherapy; 2.2.2 Stem Cell Transplantation; 2.2.3 SCT for Pediatric Refractory AML; 2.3 Chronic Myeloid Leukemia (CML); 2.3.1 Chemotherapy; 2.3.2 SCT for CML; 2.3.3 A "Big Picture" of the Pediatric CML Treatment; 2.4 Hodgkin Lymphoma; 2.4.1 Chemotherapy; 2.5 Non-Hodgkin Lymphoma; 2.5.1 Chemotherapy; 2.6 Osteosarcoma; 2.6.1 Chemotherapy; 2.6.2 Folinic Acid Mechanism; 2.7 Central Nervous System Tumors; 2.7.1 Treatment; 2.8 Retinoblastoma
2.8.1 Treatment2.8.1.1 Chemotherapy; 2.9 Wilms Tumor; 2.9.1 Treatment; 2.10 Hepatoblastoma; 2.10.1 Treatment; 2.11 Congenital Tumors; 2.11.1 Treatment; Chapter 3: Diseases in Rheumatology and Their Treatment with Chemotherapy; 3.1 Sometimes Symptoms of Rheumatic diseases Are, Actually, First Sign of Pediatric Cancer; 3.2 Rheumatic Diseases in Children and Their Treatments; 3.2.1 Pediatric Systemic Lupus Erythematosus; 3.2.2 Pediatric Idiopathic Arthritis; 3.2.3 Pediatric Dermatomyositis; 3.2.4 Pediatric Scleroderma; 3.2.5 Pediatric Kawasaki Disease
3.2.6 Pediatric Mixed Connective Tissue Disease3.2.7 Pediatric Fibromyalgia; 3.2.8 Rheumatic Diseases in Neonates and Infants; Chapter 4: Pharmacokinetics and Pharmacodynamics of Chemotherapy in Children: The Most Used Drugs; 4.1 6-mercaptopurine; 4.2 Bevacizumab; 4.3 Bleomycin; 4.4 Brentuximab; 4.5 Busulfan; 4.6 Carboplatin; 4.7 Carmustine; 4.8 Cisplatin; 4.9 Cyclophosphamide; 4.10 Cytarabine; 4.11 Dacarbazine; 4.12 Dactinomycin; 4.13 Daunorubicin; 4.14 Docetaxel; 4.15 Doxorubicin; 4.16 Etoposide; 4.17 Fludarabine; 4.18 Gemcitabine; 4.19 Hydroxyurea; 4.20 Idarubicin; 4.21 Ifosfamide
4.22 Imatinib4.23 Irinotecan; 4.24 Lomustine; 4.25 L-asparaginase; 4.26 Methotrexate; 4.27 Mitoxantrone; 4.28 Paclitaxel; 4.29 Thioguanine; 4.30 Trans-retinoic Acid; 4.31 Vinblastine; 4.32 Vincristine; 4.33 Vinorelbine; Chapter 5: Handling Parenteral Drugs Used in Chemotherapy for Children; 5.1 Brentuximab; 5.2 Bleomycin; 5.3 Busulfan; 5.4 Carboplatin; 5.5 Carmustine; 5.6 Cisplatin; 5.7 Cyclophosphamide; 5.8 Cytarabine; 5.9 Dacarbazine; 5.10 Dactinomycin; 5.11 Daunorubicin; 5.12 Docetaxel; 5.13 Doxorubicin; 5.14 Etoposide; 5.15 Fludarabine; 5.16 Gemcitabine; 5.17 Idarubicin; 5.18 Ifosfamide